Hyafilia Grand – 5th generation hybrid fillers combining the benefits of monophasic and biphasic drugs. Fillers are manufactured using the low-temperature stabilization reaction technology (L.T.S.R.). This allows getting a gel with a high density and finely packed molecular structure. Fillers are characterized by optimal viscoelasticity, are evenly distributed in the tissues, and don’t migrate during biodegradation.
Benefits of Hyafilia Grand:
- minimal risk of allergic reactions
- low residual BDDE
- smooth administration of the product reduces the risk of edema and bruising
- prolonged effect
Hyafilia Grand is the densest filler in the series, injectable into the deep layers of the dermis.
Scope of Hyafilia Grand:
- correction of deep folds
- volumetric modeling
- adding volume to the cheekbones, chin, and temporal lobes
- nose shape correction
Aesthetic effect – 12 months.
Product composition: HA 20 mg/ml
1 syringe × 1.0 ml per pack
Manufacturer: CHA Meditech Co., Ltd., South Korea
Made in Korea